🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/06/1987 | 9,16 | 9,17 | 8,96 | 9,04 | -1,09% | 2,31% | 11.827.728 |
| 29/06/1987 | 9,08 | 9,16 | 9,08 | 9,14 | +0,29% | 0,88% | 5.740.315 |
| 26/06/1987 | 9,08 | 9,12 | 9,04 | 9,11 | +0,29% | 0,88% | 4.540.565 |
| 25/06/1987 | 9,03 | 9,10 | 9,00 | 9,08 | +0,88% | 1,17% | 6.674.083 |
| 24/06/1987 | 9,01 | 9,09 | 8,98 | 9,01 | -0,37% | 1,25% | 7.017.408 |
| 23/06/1987 | 9,03 | 9,08 | 8,99 | 9,04 | +0,89% | 0,95% | 9.805.507 |
| 22/06/1987 | 8,83 | 8,97 | 8,81 | 8,96 | +1,96% | 1,80% | 9.005.674 |
| 19/06/1987 | 8,64 | 8,81 | 8,61 | 8,79 | +2,08% | 2,30% | 17.937.778 |
| 18/06/1987 | 8,67 | 8,69 | 8,59 | 8,61 | -0,99% | 1,15% | 5.272.488 |
| 17/06/1987 | 8,78 | 8,79 | 8,69 | 8,69 | -0,76% | 1,13% | 4.419.835 |
| 16/06/1987 | 8,79 | 8,81 | 8,75 | 8,76 | -0,38% | 0,68% | 4.046.328 |
| 15/06/1987 | 8,77 | 8,85 | 8,72 | 8,79 | +0,84% | 1,44% | 9.115.085 |
| 12/06/1987 | 8,79 | 8,80 | 8,72 | 8,72 | -0,08% | 0,90% | 8.639.712 |
| 11/06/1987 | 8,80 | 8,81 | 8,69 | 8,73 | -0,53% | 1,36% | 6.238.325 |
| 10/06/1987 | 8,71 | 8,85 | 8,67 | 8,77 | +1,30% | 2,13% | 12.008.822 |
| 09/06/1987 | 8,64 | 8,66 | 8,55 | 8,66 | +0,38% | 1,30% | 8.800.056 |
| 08/06/1987 | 8,49 | 8,67 | 8,48 | 8,63 | +1,24% | 2,19% | 6.208.142 |
| 05/06/1987 | 8,48 | 8,53 | 8,45 | 8,52 | +0,39% | 1,02% | 8.411.458 |
| 04/06/1987 | 8,47 | 8,50 | 8,42 | 8,49 | +0,55% | 1,02% | 8.679.326 |
| 03/06/1987 | 8,26 | 8,45 | 8,22 | 8,44 | +3,07% | 2,73% | 10.978.848 |
| 02/06/1987 | 8,30 | 8,31 | 8,19 | 8,19 | -1,28% | 1,44% | 7.136.251 |
| 01/06/1987 | 8,43 | 8,43 | 8,27 | 8,30 | -1,18% | 1,89% | 7.334.323 |
| 29/05/1987 | 8,47 | 8,48 | 8,36 | 8,40 | +0,24% | 1,49% | 8.349.206 |
| 28/05/1987 | 8,24 | 8,39 | 8,22 | 8,38 | +2,26% | 2,09% | 12.963.341 |
| 27/05/1987 | 8,19 | 8,25 | 8,14 | 8,19 | +1,23% | 1,29% | 10.499.702 |
| 26/05/1987 | 8,18 | 8,20 | 8,01 | 8,09 | -0,25% | 2,35% | 8.807.602 |
| 22/05/1987 | 7,98 | 8,11 | 7,98 | 8,11 | +1,49% | 1,58% | 5.298.898 |
| 21/05/1987 | 7,99 | 8,03 | 7,95 | 7,99 | +1,26% | 0,99% | 6.862.723 |
| 20/05/1987 | 7,81 | 7,91 | 7,79 | 7,89 | +0,93% | 1,53% | 13.431.168 |
| 19/05/1987 | 7,99 | 7,99 | 7,82 | 7,82 | -1,01% | 2,16% | 11.429.698 |